Just trimmed a portion of the position on $TEM for take-profit; the rest is still being held.
The price has already pushed up to the upper end of the previous sideways range. Short-term profit-taking has increased, so it’s reasonable to take some off. This isn’t bearish—it’s just that I don’t want to give back all the unrealized gains.
The reasons to stay bullish are still there: overall market sentiment hasn’t turned bad, and when there’s a pullback there’s also support below. As long as it doesn’t break below the breakout point of this leg, the structure remains bullish.
There are two things to watch out for. First, it’s risen quickly—if the broader market weakens, these high-beta, fast-moving names can retrace even faster. Second, there are plenty of trapped positions near the upper whole-number price levels. On the first push, it will likely grind rather than break through in one go. Don’t expect it to clear that level in a single shot.
In terms of the narrative, it’s tied to the AI-to-healthcare implementation theme. That storyline has been brought back into focus, but it hasn’t reached the point where money is rushing in. The actual inflows are still a notch behind the hottest few themes. The story can support the move, but it can’t justify blindly chasing higher; it’s better to follow the trend.
Today’s news says that real-time quote access on the stock side will be opened to Indian investors. It’s not a hard positive, but it shows that attention toward this name on the stock market side is still expanding outward. Sentiment-wise that’s a tailwind, and it also helps explain why, when it pulls back, there are always buyers.
At this level, trim a portion and keep the rest—see whether it can chew through the upper whole-number resistance. If it manages to break above and hold, there may be more room; if it can’t punch through after repeated attempts, then you have to accept that this was only a rebound.
The price has already pushed up to the upper end of the previous sideways range. Short-term profit-taking has increased, so it’s reasonable to take some off. This isn’t bearish—it’s just that I don’t want to give back all the unrealized gains.
The reasons to stay bullish are still there: overall market sentiment hasn’t turned bad, and when there’s a pullback there’s also support below. As long as it doesn’t break below the breakout point of this leg, the structure remains bullish.
There are two things to watch out for. First, it’s risen quickly—if the broader market weakens, these high-beta, fast-moving names can retrace even faster. Second, there are plenty of trapped positions near the upper whole-number price levels. On the first push, it will likely grind rather than break through in one go. Don’t expect it to clear that level in a single shot.
In terms of the narrative, it’s tied to the AI-to-healthcare implementation theme. That storyline has been brought back into focus, but it hasn’t reached the point where money is rushing in. The actual inflows are still a notch behind the hottest few themes. The story can support the move, but it can’t justify blindly chasing higher; it’s better to follow the trend.
Today’s news says that real-time quote access on the stock side will be opened to Indian investors. It’s not a hard positive, but it shows that attention toward this name on the stock market side is still expanding outward. Sentiment-wise that’s a tailwind, and it also helps explain why, when it pulls back, there are always buyers.
At this level, trim a portion and keep the rest—see whether it can chew through the upper whole-number resistance. If it manages to break above and hold, there may be more room; if it can’t punch through after repeated attempts, then you have to accept that this was only a rebound.
